Phase II Study of Revlimid [lenalidomide], Oral Cyclophosphamide and Prednisone (RCP) for Patients With Newly Diagnosed Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Cyclophosphamide (Primary) ; Lenalidomide (Primary) ; Prednisone (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 18 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Dec 2012 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 07 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.